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ABSTRACT
Breast cancer (BC) is the main common cause of cancer mortality among women in the 
world. This study aims at investigating BC epidemiology and identifying the different risk 
factors associated and the most affecting ones among women in the Gaza Strip, Palestine. 
This study was a hospital-based case-control (1:2), as the study was carried out over the 
period of October 2014 to February 2015. A total of 105 BC patients, chosen from Al-Shifa 
Hospital in Gaza City and European hospital for the south governorate, were the case and 
compared to 209 women as a control group who matched the cases in age, residence, and 
with no history of breast problems. The age of the enrolled cases and controlled ranged 
between 18 to 60 years. The face-to-face interview was conducted during the patient visit 
to the oncology department and the control visit in their home. The result illustrated that 
women who had late pregnancy (> 35 years) (odds ratio [OR], 11.56; 95% confidence interval 
[CI], 1.64–81.35), or high body mass index (BMI; ≥ 30 kg/m2) (OR, 4.70; 95% CI, 1.62–13.69), 
or first-degree family history of BC (OR, 2.7; 95% CI, 1.04–7.20), or hypertensive patients 
(OR, 12.13; 95% CI, 1.93–76.10), or diabetic (OR, 6.84; 95% CI, 1.77–26.36) were more likely 
to have increased BC risk. The findings of the present study suggest that positive family 
history of BC, high BMI, and some common diseases (hypertension, diabetes mellitus) may 
be the epigenetic factors promoting the occurrence of BC.
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INTRODUCTION
Breast cancer (BC) is the main common cause of cancer mortality among women in the world 
[1]. Age, and family history are the most critical BC risk factors [2,3]. Among Palestinian 
women, it is 30.6 percent of women's cancer and the incident rate is 78.9 per 100,000 women 
in 2014 and increased to 83.9 per 100,000 in 2015 [4,5]. However, few studies have tackled 
the risk factors of BC in Palestine [6]. The problem of BC is noticeably growing in developed 
and developing countries. In various regions, BC is the most frequently occurring malignant 
disease among women and comprises 18% of all female cancer [7]. Annually, a million—new 
case of female BC are diagnosed worldwide, most of them are in developed countries [8].
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BC is cancer that starts in the cells of the breast in women and men. Generally, it refers 
to a malignancy in women that arises from the terminal ductal-lobular units of epithelial 
tissue, which represent 10% of the total volume in the mature breast [9]. The proportion 
of BC in Palestine is like that in the neighbouring countries unlike to those in Lebanon, 
as BC accounts for nearly half of all cancers among Lebanese women [10]. According to 
the preliminary interview with the director of women health department doctor Sawsan 
Hammad, BC available services in Gaza Strip are 20 mammogram machines distributed all 
over Gaza governorates. In this regard, 5 mammogram machines are in governmental service 
as 4 are functioning and the 5th is out of order. The remaining 15 mammogram machines are 
in the private and non-governmental organization. She added that Ministry of Health (MOH) 
services are for free. However, in the private services, the screening mammogram must be 
paid, as patients pay from 10–15 USD. Due to certain factors such as; high total fertility rate 
(4.6%), high rate of breastfeeding (95.6%) with a mean duration of 10.9 months, young 
mean age at first birth (20 years), and no alcohol consumption, the Palestinian women are 
protected against BC [6]. However, reports from MOH and other studies concerning the 
Palestinian community have shown an increase incidence of BC [4]. Moreover, there are 
limited studies and insufficient knowledge about this disease in the developing countries. 
It is worth mentioning that risk factors are associated with the development of BC were not 
studied before among the women in Gaza after the war 2014.
This study aimed at exploring the various risk factors associated with the development of 
BC in women in the Gaza Strip, Palestine. This study may help to understand the interaction 
of these factors that find a way for cancer development among the Palestinian women in 
order to set guidelines for prevention strategies of BC in Palestine.
MATERIALS AND METHODS
The hospital-based case-control study collected information on women residing in the Gaza 
Strip, as the age of the enrolled cases and controlled ranged between 18 to 60 years old. 
Geographical location and age were matched for both the case and control groups (with an 
interval of ± 3 years). The data of the cases of this study was collected in the Department of 
Oncology at Al-Shifa Hospital in the Gaza City and the European hospital, over the period of 
October 2014 to February 2015.
The selected cases were recorded and confirmed during the period beyond 2014 in 
cooperation with cancer registry centre to revise documents of the patients. Face-to-face 
interview was conducted during the patient visit to the oncology department.
A hospital-based group matched case-control study was conducted to identify BC risk 
factors. The study tackled of 105 hospitalized cases confirmed on histopathology and 209 
group-matched controls selected from same geographical area without history of breast 
problems or neoplastic disease and not had any other cancers. Two controls from the 
neighbours of these cases were visited at home to be studied. Written approval was obtained 
from the MOH to access the patients' records from the oncology department and cancer 
registry. Meanwhile, written consent form was obtained from the study sample.
Different risk factors (independent variables) that may interfere in BC were studied. A 
structured questionnaire included; the status of education, menstruation cycle, the induced 
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abortion history, first-degree family history of BC, parity, number of full-term pregnancies, 
duration of breastfeeding (month), age at first pregnancy (year), age at menarche, history of 
irregular menstruation, spontaneous abortion, history, duration of using oral contraceptives, 
benign breast disease personal history, smoking, body mass index (BMI), hypertension (HT), 
and diabetes.
Anthropometric measurements, with 2 variables height and weight were used. Body weight 
of each participant was measured by using a calibrated scale (Seca model 750 1017009; Seca 
GmbH, Hamburg, Germany). Participants were weighed barefooted to the nearest 0.5 kg. 
Using the stadiometer (Seca body meter 206; Seca GmbH), height was approximated to the 
nearest 0.5 cm without shoes, the shoulders in a relaxed position, and the arms hanging 
freely. A single derived variable BMI was used in this study.
SPSS version 21 (IBM Corp., Chicago, IL, USA) was used for the data analysis, as bivariate and 
multivariate conditional logistic regression was used to assess the association of BC with 
independent variables and crude and adjusted odds ratio (OR) and related 95% confidence 
intervals (CIs) were calculated to determine the precision of the estimates. The level of 
significance used was 5%. The p value < 0.05 indicated significance.
RESULTS
The distribution of patients with BC (n = 105) and control (n = 209), according to socio-
demographic characteristics (age, governorates, resident, locality of residence, and home 
type) is shown in Table 1. The age of the majority of the study sample was above 40, while the 
majority of them were city inhabitants.
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Table 1. Study population distribution according to the socio-demographic factors
Characteristics Case (n = 105) Control (n = 209)
Frequency % Frequency %
Age, yr
18–25 2 1.9 26 12.4
26–40 20 19.0 57 27.3
> 40 83 79.0 126 60.3
Governorate
North G 17 16.2 32 15.3
Gaza City G 48 45.7 97 46.4
Middle G 16 15.2 31 14.8
South G 24 22.9 49 23.4
Residence
City 71 67.6 136 65.1
Village 7 6.7 14 6.7
Camp 27 25.7 59 28.2
Locality of residence
Agricultural 22 21.0 42 20.1
Industrial 24 22.9 44 21.1
Borderline 16 15.2 46 22.0
Towers 43 41.0 77 36.8
Home type
Villa 1 1.0 2 1.0
Flat 49 46.7 78 37.3
Separated home 48 45.7 87 41.6
Asbestoses home 7 6.7 42 20.1
G, governorate.
According to BMI, marital status, age at marriage and education, the distribution of patients 
with BC (n = 105) and control (n = 209) as shown in Table 2. The BMI ≥ 30 kg/m2 was reported 
among 58.3% of the cases and among 30.5% of the control. Regarding marriage age, i.e., less 
19 years old, 42.7% was among the cases while 35.9% among the control.
Table 3 shows the distribution of the study population according to some reproductive health 
factors. Regarding the age of menarche, the table shows that double percent among the cases 
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Table 2. Study population women distribution according to the social status and BMI
Characteristics Case (n = 105) Control (n = 209)
No. % No. %
BMI, kg/m2
< 30 43 41.7 137 69.5
≥ 30 60 58.3 60 30.5
Marital status
Single 8 7.6 11 5.3
Married 81 77.1 160 76.6
Widow 13 12.4 25 12.0
Separate 3 2.9 13 6.2
Marriage age, yr
< 19 42 42.7 71 35.9
≥ 19 55 57.3 127 64.1
Education
High 61 58.1 128 61.2
Low 44 41.9 81 38.8
BMI, body mass index.
Table 3. study population women distribution according to the reproductive health factors, passive smoking, examination of breast, and other factors
Characteristics Case Control
Frequency % Frequency %
Age at menarche, yr
≤ 11 11 10.5 12 5.8
12–15 84 80.0 163 78.9
> 15 10 9.5 32 15.5
Menopause
Yes 63 60.0 60 28.7
No 42 40.0 149 71.3
No. of children
Null parameter 19 18.1 23 11.0
< 3 6 5.7 39 18.7
3–5 24 22.9 53 25.4
> 5 56 53.3 94 45.0
Age at full pregnancy, yr
≤ 18 25 29.4 39 20.7
19–25 44 51.8 132 70.2
> 25 16 18.8 17 9.0
Breastfeeding
Yes 77 87.5 176 92.1
No 11 12.5 15 7.9
Contraceptive pills
Yes 27 28.1 57 28.9
No 69 71.9 140 71.1
Passive smoking
Yes 54 51.4 85 40.7
No 51 48.6 124 59.3
Examination of breast
Yes 17 16.2 24 11.5
No 88 83.8 185 88.5
have menstruation before the age of 11 compared to the control. It also shows that women 
with more than 5 children and those of null parlous are more among the cases compared to 
the control.
Table 4 shows the distribution of study population according to the family history and some 
chronic diseases that are common in the Gaza Strip. The table shows that 81.6% were first-
degree relatives of BC patients among the cases, while 61.9% were among the control. The 
same table shows that 24.8% and 21.0% were diabetes and hypertensive among the cases, 
while 6.2% and 7.7% among the control.
Table 5 shows the risk factors that increased BC, as women that had a late pregnancy (> 35 
years) (OR, 11.56; 95% CI, 1.64–81.35) and those with BMI (≥ 30 kg/m2) (OR, 4.70; 95% CI, 
1.62–13.69). It also shows that first-degree family history of BC (OR, 2.7; 95% CI, 1.04–7.20), 
while hypertensive patients (OR, 12.13; 95% CI, 1.93–76.10), and those with diabetes mellitus 
(DM) (OR, 6.84; 95% CI, 1.77–26.36).
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Table 4. The control and case groups regarding medical history factors
Factors Case Control
Family history of any type of cancer
Yes 58 (55.2) 64 (30.6)
No 47 (44.8) 145 (69.4)
Family history of BC
Yes 38 (36.2) 63 (30.1)
No 67 (63.8) 146 (69.9)
Relative
First-degree relative 31 (81.6) 39 (61.9)
Second-degree relative 7 (18.4) 24 (38.1)
DM
Yes 26 (24.8) 13 (6.2)
No 79 (75.2) 196 (93.8)
HT
Yes 22 (21.0) 16 (7.7)
No 83 (79.0) 193 (92.3)
Toxaemia during pregnancy
Yes 4 (3.8) 17 (8.1)
No 101 (96.2) 192 (91.9)
Iron deficiency anaemia
Yes 6 (5.7) 20 (9.6)
No 99 (94.3) 189 (90.4)
Values are presented as number (%).
BC, breast cancer; DM, diabetes mellitus; HT, hypertension.
Table 5. Risk factors associated with increased or decreased risk of BC
Factors Control, % Case, % OR (95% CI) p value
Factors associated with increased BC risk
Late pregnancy (> 35 yr) 9.0 18.8 11.560 (1.640–81.350) 0.014
BMI (> 30 kg/m2) 30.5 58.3 4.700 (1.620–13.690) 0.005
Family history of BC (first-degree relative) 61.9 81.6 2.700 (1.040–7.200) 0.039
HT 7.7 21.0 12.130 (1.930–76.100) 0.008
DM 24.8 6.2 6.840 (1.770–26.360) 0.005
Factors associated with decreased BC risk
Late age at menarche 15.3 9.5 0.111 (0.014–0.904) 0.040
Nulliparous 11.0 18.1 0.003 (0.000–0.557) 0.029
Women (≥ 5 children) 45.0 53.3 0.003 (0.000–0.644) 0.034
BC, breast cancer; OR, odds ratio; CI, confidence interval, BMI, body mass index; HT, hypertension; DM, diabetes mellitus.
DISCUSSION
The findings of this study have revealed several risk factors for BC among women living in the 
Gaza Strip. These factors were found to be associated with increased BC risk including late 
pregnancy (> 35 years), high BMI, first-degree relative history, HT, and diabetes. While there 
was no reported statistical association concerning the place of living, exposure to passive 
smoking or even being breastfed. On the other hand, several factors seemed to be protective 
factors for BC including null parity, women with more than 5 children, and the age at first 
menstrual period “menarche.”
Wide ranging investigations have uncovered that when compared to women without a family 
history of BC, women with a first-degree relative (mother or sister) diagnosed with BC face 
almost twice the possibility of contracting this ailment. This possibility is aggravated in 
a situation where the number of relatives stricken with BC is two or more [11]. It is fairly 
accurate to surmise that in developed countries, 25% of inter-individual differences linked to 
BC exposure is attributed to genetic issues, while the remaining 75% is attributed to issues 
concerning the individual's surroundings and way of life [12].
The present study revealed a relationship with statistical significant between BC and the 
family history. This familial association for women in Gaza is likely to imply a genetic 
predisposition. Therefore, it is of interest to investigate more about this association to 
determine the responsible gene.
A different conclusion has been observed regarding the exposure to passive smoking, 
using the contraceptive pills and practising of breastfeeding with the incidence of BC, as 
there were no statistically significant relationships.
According to results derived from investigations on several ethnic groups, the threat of BC is 
elevated during an older woman's first full-term pregnancy [13-16]. In contrast, other studies 
revealed different results which were inconsistent with our findings [17,18].
This study puts forward that pregnancy during an advanced age (35 years and more) can 
encourage the progress of existing malignancy cells. Pregnancy brings about terminal 
differentiation of human breast glands which may have a less pronounced proliferative 
element. The initial pregnancy stimulates permanent alterations that either reduce the 
vulnerability of the breast tissue to the occurrence of cancer, or decrease the carcinogenic 
stimulus to the breast [19].
A separate threat related to the development of BC is BMI. According to results attained 
from our investigations, women with a BMI in excess of 30 kg/m2 are more susceptible to BC 
than women with a BMI lower than 30 kg/m2. This revelation is in agreement with results 
acquired through previous studies [20-22]. The link between obesity and BC can be traced to 
the abundance of body fat accumulation. This situation, which contributes to the peripheral 
conversion of lipocytes into oestrogen, encourages the development of cancer cells. Another 
factor that requires consideration is excessive insulin. As insulin fuels the development of 
BC cell lines, its raised levels in obese women can heighten the threat of BC. Peptides that 
contribute towards the regulation of tissue development and fat deposition are known as 
insulin-like growth factors (IGFs). IGF-1 is an insulin-like growth factor that sets off mitosis 
in BC cells. Several epidemiologic investigations have revealed that the levels of IGF-1 may 
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be elevated in women who are obese. This circumstance exposes them to a higher risk of 
developing BC [20]. From a chemical standpoint, the raised risk of BC in obese womencan 
generally be put down to the alteration of androstenedione into adipose tissue (the main 
supplier of oestrogen in post-menopausal women). An outsized amount of adipose tissue leads 
to the development of an estrone level that is proportionate to this amount [23].
Findings of the present study also indicated a positive correlation between diabetes (type 
II diabetes) and BC. The result was consistent with another case-control and cohort study 
carried out in North America, Europe, and Asia [24]. Palestinian health reports indicated 
that chronic diseases like HT and diabetes are rising in Palestine. The increase of chronic 
diseases epidemics are propelled by social, economic, and demographic factors, of which 
urbanisation and globalisation are the main determinants [25]. The mechanisms underlying 
the relationship between diabetes and BC risk may be related to alterations in circulating 
concentrations of insulin, IGFs and endogenous sex hormones. Diabetes type II is usually 
combined with insulin resistance and increased pancreatic insulin secretion for long periods 
before and after disease onset. Insulin has been demonstrated to have mitogenic effects 
on breast tissue and insulin receptors are frequently over-expressed in BC cells. A positive 
association between circulating concentrations of insulin or C-peptide (a marker of insulin 
secretion) and BC risk has been observed in another epidemiologic study [24]. More in-depth 
investigations are needed to identify the relationship especially with the higher prevalence of 
DM in Gaza Strip.
No doubt that HT is a main cause of mortality and morbidity, especially prevalent in the 
developed world. The relationship between HT and BC is controversial. Some studies report 
a weak-to-moderate association between HT and BC in menopausal women [26-29], but this 
finding is not consistent with other studies [30-33]. Some researchers concluded observed 
association between HT and BC is confounded by obesity and high BMI, which is a risk factor 
for both BC and HT [34,35]. In the present study, HT is recorded as one of the main BC risk 
factors. Further investigations are needed to figure out whether HT, obesity, high BMI, or the 
drugs used for the treatment of HT are responsible for increasing the risk of BC. While other 
reproductive factors in this study are well established as risk factors for BC, while the rest 
reproductive factors were reported as protective factors of BC.
The results indicated that higher numbers of births are recognised as protective against BC. 
The present data provide evidence that, among nulliparous women, a high number of births 
(≥ 5 births) are associated with decreased BC risk in the target group of the study. Several 
researchers reported that the degree of BC risk faced by women who have delivered five or 
more children is half that of women who have not experienced labour and delivery [36]. 
However, other investigations disclosed that the decreased risk factor related to the raised 
number of births may be confined to hormone receptor-positive BC [37]. Then again, this 
finding is contradictory to that obtained through a different investigation [38].
The nulliparity of some women in the BC group can be put down to their non-married status 
or infertility. A significant number of researchers are convinced that nulliparous women face 
a greater risk of coming down with BC [39-41]. A study involving Norwegian women indicated 
that nulliparity and obesity can exert a synergistic influence on the BC risk of more mature 
women [42]. Contrastingly, the results from our investigations signify that instead of raising 
the risk of BC in women, nulliparity fortifies the protection against this disorder. Garland et 
al. [43] discovered that due to their lesser exposure to ovulatory cycles, women beset with 
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ovulatory infertility are less vulnerable to BC. It was also uncovered that clomiphene citrate, 
an ovulation-stimulating agent and oestrogen adversary resembling tamoxifen, is linked to the 
reduced BC risk in women who are incapable of conceiving due to infertility.
Early age at menarche is a known risk factor for BC. In the present study, women who had 
menarche at age 13–15 years old were at decreased risk compared with women who had 
menarche at an early age less than 13 year. Menarche at the age of 13–15 years was associated 
with decreased risk of BC and the difference was statistically significant (p = 0.026). This 
finding was matched with other studies from Saudi Arabia, Cyprus, and Japan [6,8,44,45]. 
Female with a menarcheal age, below 12 years, had higher serum estradiol but lower 
testosterone and dehydroepiandrosterone concentrations, compared to those with later 
menarche [46].
CONCLUSION
The strongest associations with BC risk Palestinian women population were observed with 
late age a full-term pregnancy, high BMI and first-degree family history of BC. Overall, the 
findings of current study corroborate with the results of previous investigations on descriptive 
epidemiology of risk factors for BC. However, the current study presents the first publication 
for BC risk factors among women in Gaza after war 2014 in Gaza and provides the first scientific 
evidence using local data, for executing more targeted campaigns of prevention and early 
diagnosis among Palestinian women population. More in-depth investigations are needed to 
identify the relation especially with the higher prevalence of BC in Gaza Strip, Palestine.
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